Trimethadione
Trimethadione (Tridione) is an oxazolidinedione anticonvulsant.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Trimethadione (Tridione) is an oxazolidinedione anticonvulsant. It is most commonly used to treat epileptic conditions that are resistant to other treatments. It is primarily effective in treating absence seizures, but can also be used in refractory temporal lobe epilepsy.
It is usually administered 3 or 4 times daily, with the total daily dose ranging from 900 mg to 2.4 g. Treatment is most effective when the concentration of its active metabolite, dimethadione, is above 700 μg/mL. Severe adverse reactions are possible, including Steven Johnson syndrome, nephrotoxicity, hepatitis, aplastic anemia, neutropenia, or agranulocytosis.
More common adverse effects include drowsiness, hemeralopia, and hiccups.
Fetal trimethadione syndrome
If administered during pregnancy, fetal trimethadione syndrome may result causing facial dysmorphism (short upturned nose, slanted eyebrows), cardiac defects, intrauterine growth restriction (IUGR), and intellectual disability. The fetal loss rate while using trimethadione has been reported to be as high as 87%.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1340089814 under CC BY-SA 4.0; modifications have been made.